🧠 Investors’ ‘dumb transhumanist ideas’ setting back neurotech progress, say experts / The Guardian
「 These technologies have considerable near-term potential to treat a variety of neurological issues – from ALS to Parkinson’s to paralysis. The problem is, their investors don’t always appear to have curing disease as an end goal 」